Zyxin-Siah2–Lats2 axis mediates cooperation between Hippo and TGF-β signalling pathways
暂无分享,去创建一个
Shian Wu | Quan Chen | Yushan Zhu | Ling Chen | Biao Ma | Hongcheng Cheng | Chenglong Mu | Ruize Gao
[1] N. Tapon,et al. Zyxin Antagonizes the FERM Protein Expanded to Couple F-Actin and Yorkie-Dependent Organ Growth , 2015, Current Biology.
[2] J. Li,et al. Hypoxia regulates Hippo signalling through the SIAH2 ubiquitin E3 ligase , 2014, Nature Cell Biology.
[3] Kyung-Ja Cho,et al. Epithelial-Mesenchymal Transition , 2014, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[4] G. Semenza,et al. Hypoxia-inducible factor 1 mediates TAZ expression and nuclear localization to induce the breast cancer stem cell phenotype , 2014, Oncotarget.
[5] M. Beckerle,et al. LIM proteins in actin cytoskeleton mechanoresponse. , 2014, Trends in cell biology.
[6] Giuseppe Basso,et al. YAP/TAZ Incorporation in the β-Catenin Destruction Complex Orchestrates the Wnt Response , 2014, Cell.
[7] R. Hakem,et al. LATS2 suppresses oncogenic Wnt signaling by disrupting β-catenin/BCL9 interaction. , 2013, Cell reports.
[8] O. Lee,et al. Hypoxia-Induced Secretion of TGF-β1 in Mesenchymal Stem Cell Promotes Breast Cancer Cell Progression , 2013, Cell transplantation.
[9] N. Elvassore,et al. A Mechanical Checkpoint Controls Multicellular Growth through YAP/TAZ Regulation by Actin-Processing Factors , 2013, Cell.
[10] Claire M Brown,et al. A complex containing LPP and &agr;-actinin mediates TGF&bgr;-induced migration and invasion of ErbB2-expressing breast cancer cells , 2013, Journal of Cell Science.
[11] David M. Thomas,et al. The Hippo pathway and human cancer , 2013, Nature Reviews Cancer.
[12] F. Camargo,et al. YAP mediates crosstalk between the Hippo and PI(3)K–TOR pathways by suppressing PTEN via miR-29 , 2012, Nature Cell Biology.
[13] Xiang-Dong Fu,et al. Regulation of the Hippo-YAP Pathway by G-Protein-Coupled Receptor Signaling , 2012, Cell.
[14] Stefano Piccolo,et al. Transduction of mechanical and cytoskeletal cues by YAP and TAZ , 2012, Nature Reviews Molecular Cell Biology.
[15] Hidemi Ito,et al. TGF-β synergizes with defects in the Hippo pathway to stimulate human malignant mesothelioma growth , 2012, The Journal of experimental medicine.
[16] Hidemi Ito,et al. TGF-b synergizes with defects in the Hippo pathway to stimulate human malignant mesothelioma growth , 2012 .
[17] Jindan Yu,et al. Cell detachment activates the Hippo pathway via cytoskeleton reorganization to induce anoikis. , 2012, Genes & development.
[18] Bin Zhao,et al. The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal , 2011, Nature Cell Biology.
[19] Nicola Elvassore,et al. Role of YAP/TAZ in mechanotransduction , 2011, Nature.
[20] Pedro Gaspar,et al. Actin-Capping Protein and the Hippo pathway regulate F-actin and tissue growth in Drosophila , 2011, Development.
[21] K. Basler,et al. Zyxin Links Fat Signaling to the Hippo Pathway , 2011, PLoS biology.
[22] M. Ji,et al. KIBRA Regulates Hippo Signaling Activity via Interactions with Large Tumor Suppressor Kinases* , 2011, The Journal of Biological Chemistry.
[23] Janet Rossant,et al. The Crumbs complex couples cell density sensing to Hippo-dependent control of the TGF-β-SMAD pathway. , 2010, Developmental cell.
[24] D. Pan,et al. The hippo signaling pathway in development and cancer. , 2010, Developmental cell.
[25] Marc D. H. Hansen,et al. Zyxin controls migration in epithelial–mesenchymal transition by mediating actin‐membrane linkages at cell–cell junctions , 2009, Journal of cellular physiology.
[26] K. Guan,et al. A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF(beta-TRCP). , 2010, Genes & development.
[27] Jianmin Zhang,et al. YAP-dependent induction of amphiregulin identifies a non-cell-autonomous component of the Hippo pathway , 2009, Nature Cell Biology.
[28] M. Nieto. Epithelial-Mesenchymal Transitions in development and disease: old views and new perspectives. , 2009, The International journal of developmental biology.
[29] Y. Kaneda,et al. Zyxin mediates actin fiber reorganization in epithelial-mesenchymal transition and contributes to endocardial morphogenesis. , 2009, Molecular biology of the cell.
[30] J. Massagué,et al. TGFβ in Cancer , 2008, Cell.
[31] Jiandie D. Lin,et al. TEAD mediates YAP-dependent gene induction and growth control. , 2008, Genes & development.
[32] J. Clements,et al. Epithelial—mesenchymal and mesenchymal—epithelial transitions in carcinoma progression , 2007, Journal of cellular physiology.
[33] Li Li,et al. Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. , 2007, Genes & development.
[34] G. Feldmann,et al. Elucidation of a Universal Size-Control Mechanism in Drosophila and Mammals , 2007, Cell.
[35] B. Edgar,et al. Filling out the Hippo pathway , 2007, Nature Reviews Molecular Cell Biology.
[36] A. Moustakas,et al. Actions of TGF-β as tumor suppressor and pro-metastatic factor in human cancer , 2007 .
[37] A. Moustakas,et al. Actions of TGF-beta as tumor suppressor and pro-metastatic factor in human cancer. , 2007, Biochimica et biophysica acta.
[38] Brian Bierie,et al. TGF- and cancer , 2006 .
[39] Masaaki Yoshigi,et al. Mechanical force mobilizes zyxin from focal adhesions to actin filaments and regulates cytoskeletal reinforcement , 2005, The Journal of cell biology.
[40] Jianbin Huang,et al. The Hippo Signaling Pathway Coordinately Regulates Cell Proliferation and Apoptosis by Inactivating Yorkie, the Drosophila Homolog of YAP , 2005, Cell.
[41] C. Lewis,et al. Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues. , 2004, Blood.
[42] G. Rodan,et al. The LATS2/KPM tumor suppressor is a negative regulator of the androgen receptor. , 2004, Molecular endocrinology.
[43] J. Brown,et al. Exploiting tumour hypoxia in cancer treatment , 2004, Nature Reviews Cancer.
[44] Ray Keller,et al. Mechanisms, mechanics and function of epithelial–mesenchymal transitions in early development , 2003, Mechanisms of Development.
[45] N. Tapon,et al. The Salvador partner Hippo promotes apoptosis and cell-cycle exit in Drosophila , 2003, Nature Cell Biology.
[46] Ryan S. Udan,et al. Hippo promotes proliferation arrest and apoptosis in the Salvador/Warts pathway , 2003, Nature Cell Biology.
[47] Shian Wu,et al. hippo Encodes a Ste-20 Family Protein Kinase that Restricts Cell Proliferation and Promotes Apoptosis in Conjunction with salvador and warts , 2003, Cell.
[48] I. Hariharan,et al. The Drosophila Mst Ortholog, hippo, Restricts Growth and Cell Proliferation and Promotes Apoptosis , 2003, Cell.
[49] J. Massagué,et al. Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer. , 2003, Nature reviews. Cancer.
[50] Xiu-fen Lei,et al. Autocrine TGFβ supports growth and survival of human breast cancer MDA-MB-231 cells , 2002, Oncogene.
[51] Xiu-fen Lei,et al. Autocrine TGFbeta supports growth and survival of human breast cancer MDA-MB-231 cells. , 2002, Oncogene.
[52] Katsuyoshi Hatakeyama,et al. Zyxin, a Regulator of Actin Filament Assembly, Targets the Mitotic Apparatus by Interacting with H-Warts/Lats1 Tumor Suppressor , 2000, The Journal of cell biology.
[53] N. Copeland,et al. Title Structure , Expression , and Chromosome Mapping of LATS 2 , a Mammalian Homologue of the Drosophila Tumor Suppressor Gene lats / warts , 2022 .
[54] W. Tao,et al. Human homologue of the Drosophila melanogaster lats tumour suppressor modulates CDC2 activity , 1999, Nature Genetics.
[55] M. Reiss. TGF-beta and cancer. , 1999, Microbes and infection.